Expression of the antiapoptotic protein survivin in colon cancer

Clinical Colorectal Cancer

Volumn 10, Issue 3, 2011, Pages 188-193

  Hernandez, Jonathan M ^a   Farma, Jeffrey M ^b   Coppola, Domenico ^a   Hakam, Ardeshir ^a   Fulp, William J ^a   Chen, Dung Tsa ^a   Siegel, Erin M ^a   Yeatman, Timothy J ^a   Shibata, David ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Apoptosis; Colon cancer; Immunohistochemistry; PUMA; Survivin

Indexed keywords

PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN MCL 1; PUMA PROTEIN; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; COLON ADENOCARCINOMA; COLON ADENOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RNA ANALYSIS; TISSUE MICROARRAY; UPREGULATION;

EID: 80052506407     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.03.014     Document Type: Article

References (56)

1. L. Qiao, and B.C. Wong Targeting apoptosis as an approach for gastrointestinal cancer therapy Drug Resist Updat 12 2009 55 64
2. S. Cory, and J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat Rev Cancer 2 2002 647 656 (Pubitemid 37328916)
3. G.S. Salvesen, and C.S. Duckett IAP proteins: blocking the road to death's door Nat Rev Mol Cell Biol 3 2002 401 410 (Pubitemid 34685698)
4. N. Zaffaroni, M. Pennati, and M.G. Daidone Survivin as a target for new anticancer interventions J Cell Mol Med 9 2005 360 372
5. M. Pennati, M. Folini, and N. Zaffaroni Targeting survivin in cancer therapy: fulfilled promises and open questions Carcinogenesis 28 2007 1133 1139 (Pubitemid 47062670)
6. M. Pennati, M. Folini, and N. Zaffaroni Targeting survivin in cancer therapy Expert Opin Ther Targets 12 2008 463 476 (Pubitemid 351551639)
7. A. Islam, H. Kageyama, and N. Takada High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma Oncogene 19 2000 617 623 (Pubitemid 30102912)
8. G.M. Kasof, and B.C. Gomes Livin, a novel inhibitor of apoptosis protein family member J Biol Chem 276 2001 3238 3246
9. A. Suzuki, T. Ito, and H. Kawano Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death Oncogene 19 2000 1346 1353 (Pubitemid 30160627)
10. I. Tamm, Y. Wang, and E. Sausville IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res 58 1998 5315 5320 (Pubitemid 28551107)
11. D.C. Altieri Targeted therapy by disabling crossroad signaling networks: the survivin paradigm Mol Cancer Ther 5 2006 478 482
12. D. Grossman, J.M. McNiff, and F. Li Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma J Invest Dermatol 113 1999 1076 1081 (Pubitemid 30013356)
13. M. Ikeguchi, T. Ueta, and Y. Yamane Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma Clin Cancer Res 8 2002 3131 3136 (Pubitemid 35155022)
14. J. Kato, Y. Kuwabara, and M. Mitani Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 95 2001 92 95 (Pubitemid 32187079)
15. C.D. Lu, D.C. Altieri, and N. Tanigawa Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas Cancer Res 58 1998 1808 1812 (Pubitemid 28217451)
16. M. Monzo, R. Rosell, and E. Felip A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers J Clin Oncol 17 1999 2100 2104 (Pubitemid 29318841)
17. K. Satoh, K. Kaneko, and M. Hirota Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors Cancer 92 2001 271 278 (Pubitemid 32664432)
18. K. Tanaka, S. Iwamoto, and G. Gon Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 2000 127 134 (Pubitemid 30064984)
19. H. Yoshida, O. Ishiko, and T. Sumi Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas Int J Oncol 19 2001 537 542
20. A.S. Parker, F. Kosari, and C.M. Lohse High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma Cancer 107 2006 37 45 (Pubitemid 43939028)
21. K. Soreide, E. Gudlaugsson, and I. Skaland Metachronous cancer development in patients with sporadic colorectal adenomasmultivariate risk model with independent and combined value of hTERT and survivin Int J Colorectal Dis 23 2008 389 400
22. R.N. Van Gelder, M.E. von Zastrow, and A. Yool Amplified RNA synthesized from limited quantities of heterogeneous cDNA Proc Natl Acad Sci U S A 87 1990 1663 1667
23. K.K. Dobbin, D.G. Beer, and M. Meyerson Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays Clin Cancer Res 11 2005 565 572 (Pubitemid 40116881)
24. R.A. Irizarry, B. Hobbs, and F. Collin Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
25. N. Kabra, Z. Li, and L. Chen SirT1 is an inhibitor of proliferation and tumor formation in colon cancer J Biol Chem 284 2009 18210 18217
26. T. Ponnelle, C. Chapusot, and L. Martin Cellular localisation of survivin: impact on the prognosis in colorectal cancer J Cancer Res Clin Oncol 131 2005 504 510 (Pubitemid 41215305)
27. L.J. Lin, C.Q. Zheng, and Y. Jin Expression of survivin protein in human colorectal carcinogenesis World J Gastroenterol 9 2003 974 977 (Pubitemid 36681663)
28. F. Fogt, C. Poremba, and K. Shibao Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis Appl Immunohistochem Mol Morphol 9 2001 143 149 (Pubitemid 32477202)
29. M. Alper, S. Cukur, and O. Belenli Evaluation of the immunohistochemical stain patterns of survivin, Bak and Bag-1 in colorectal cancers and comparison with polyps situated in the colon Hepatogastroenterology 55 2008 1269 1273
30. T. Mikami, T. Yoshida, and F. Akino Apoptosis regulation differs between ulcerative colitisassociated and sporadic colonic tumors Association with survivin and bcl-2 Am J Clin Pathol 119 2003 723 730 (Pubitemid 37046394)
31. V.E. Velculescu, S.L. Madden, and L. Zhang Analysis of human transcriptomes Nat Genet 23 1999 387 388
32. A. Abd El-Hameed Survivin expression in colorectal adenocarcinoma using tissue microarray J Egypt Natl Canc Inst 17 2005 42 50
33. F. Li, E.J. Ackermann, and C.F. Bennett Pleiotropic cell-division defects and apoptosis induced by interference with survivin function Nat Cell Biol 1 1999 461 466 (Pubitemid 129503664)
34. U. Zangemeister-Wittke Antisense to apoptosis inhibitors facilitates chemotherapy and TRAIL-induced death signaling Ann N Y Acad Sci 1002 2003 90 94 (Pubitemid 38253333)
35. E.A. Hirschowitz, T. Foody, and R. Kryscio Autologous dendritic cell vaccines for non-small-cell lung cancer J Clin Oncol 22 2004 2808 2815 (Pubitemid 41079898)
36. G.I. Shapiro Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol Clin Cancer Res 10 2004 4270s 4275s (Pubitemid 38812461)
37. J. Turkson STAT proteins as novel targets for cancer drug discovery Expert Opin Ther Targets 8 2004 409 422 (Pubitemid 39359648)
38. W. Xia, C.M. Gerard, and L. Liu Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells Oncogene 24 2005 6213 6221 (Pubitemid 43080044)
39. F. Paduano, R. Villa, and M. Pennati Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells Mol Cancer Ther 5 2006 179 186
40. A. Biran, M. Brownstein, and R. Haklai Downregulation of survivin and aurora a by histone deacetylase and RAS inhibitors: A new drug combination for cancer therapy Int J Cancer 128 2011 691 701
41. E.J. Kim, S.Y. Park, and J.Y. Lee Fucoidan present in brown algae induces apoptosis of human colon cancer cells BMC Gastroenterol 10 2010 96
42. H.F. Liu, H.C. Hu, and J.I. Chao Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells Chem Biol Interact 188 2010 535 545
43. S. Sreevalsan, I. Jutooru, and G. Chadalapaka 1,1-Bis(3′-indolyl)- 1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells Int J Oncol 35 2009 1191 1199
44. P.C. Sun, C. Tzao, B.H. Chen, C.W. Liu, C.P. Yu, and J.S. Jin Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells J Biomed Sci 17 2010 76
45. T. Ishihara, T. Hoshino, and T. Namba Involvement of up-regulation of PUMA in non-steroidal anti-inflammatory drug-induced apoptosis Biochem Biophys Res Commun 356 2007 711 717 (Pubitemid 46499023)
46. H.F. Liu, P.W. Hsiao, and J.I. Chao Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells Chem Biol Interact 176 2008 48 57
47. P.C. Konturek, K. Rembiasz, and G. Burnat Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer Dig Dis Sci 51 2006 779 787
48. T. de La Motte Rouge, and L. Galluzzi A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib Cancer Res 67 2007 6253 6262 (Pubitemid 47037507)
49. P. Fortugno, E. Beltrami, and J. Plescia Regulation of survivin function by Hsp90 Proc Natl Acad Sci U S A 100 2003 13791 13796 (Pubitemid 37499145)
50. Q. Sun, L. Ming, and S.M. Thomas PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells Oncogene 28 2009 2348 2357
51. P.A. Kenny TACE: a new target in epidermal growth factor receptor dependent tumors Differentiation 75 2007 800 808 (Pubitemid 350086166)
52. Y. Yan, J. Zhang, and J.L. Guo Multiple shRNA-mediated knockdown of TACE reduces the malignancy of HeLa cells Cell Biol Int 33 2009 158 164
53. N.B. Merchant, I. Voskresensky, and C.M. Rogers TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer Clin Cancer Res 14 2008 1182 1191 (Pubitemid 351302567)
54. K.J. Townsend, J.L. Trusty, and M.A. Traupman Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C Oncogene 17 1998 1223 1234 (Pubitemid 28446162)
55. T. Gallenne, F. Gautier, and L. Oliver Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members J Cell Biol 185 2009 279 290
56. W.X. Zong, T. Lindsten, and A.J. Ross BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak Genes Dev 15 2001 1481 1486 (Pubitemid 32552527)